scorecardresearch
Follow Us:
Wednesday, March 03, 2021

WHO-led Covax vaccine scheme agrees to new supply deal with Serum Institute of India

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.

By: Reuters |
February 3, 2021 10:08:22 pm
Serum institute of india, deal between serum institute of India and covax vaccine scheme, WHO on covid vaccine, coronavirus vaccine, unicef chief Henrietta ForeSerum Institute of India enters into a deal with WHO-led Covax Vaccine Scheme to supply 1.1 bn doses of AstraZeneca and Novavax.

India’s Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the U.N. Children’s Fund said on Wednesday.

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries. They would be produced by Serum under a technology transfer agreement, she said in a briefing.

The COVAX facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and UNICEF.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest World News, download Indian Express App.

0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement